MML Investors Services
ITCI

MML Investors Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

MML Investors Services’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,784
Closed -$400K – 2829
2024
Q4 		$400K Buy
4,784
+787
+20% +$64.7K ﹤0.01% 2065
2024
Q3 		$292K Sell
3,997
-133
-3% -$10K ﹤0.01% 2201
2024
Q2 		$283K Sell
4,130
-5,499
-57% -$381K ﹤0.01% 2122
2024
Q1 		$666K Buy
9,629
+2,321
+32% +$160K ﹤0.01% 1641
2023
Q4 		$523K Sell
7,308
-1,937
-21% -$111K ﹤0.01% 1728
2023
Q3 		$482K Buy
9,245
+5,603
+154% +$326K ﹤0.01% 1658
2023
Q2 		$231K Sell
3,642
-1,117
-23% -$69.6K ﹤0.01% 2088
2023
Q1 		$258K Buy
4,759
+833
+21% +$40.3K ﹤0.01% 1772
2022
Q4 		$208K Buy
+3,926
New +$197K ﹤0.01% 2009
2021
Q1 		– Sell
-9,570
Closed -$304K – 1846
2020
Q4 		$304K Buy
+9,570
New +$252K ﹤0.01% 1386
2020
Q3 		– Sell
-31,200
Closed -$801K – 1619
2020
Q2 		$801K Buy
+31,200
New +$632K 0.01% 798

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

MML Investors Services's ITCI Position: Q1 2025 in Review

MML Investors Services sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 4,784 shares — an estimated $400K sold.

MML Investors Services first reported a position in ITCI in Q2 2020 and held it in 11 quarters. The position peaked at $801K in Q2 2020. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • MML Investors Services reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • MML Investors Services sold 4,784 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $400K.
  • MML Investors Services first reported a position in Intra-Cellular Therapies Inc. in Q2 2020 and held it in 11 quarters.
  • MML Investors Services's Intra-Cellular Therapies Inc. position peaked at $801K in Q2 2020.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.